Figure 1. Pre- and posttreatment CT scans of the responding patient. Arterial phase CT scans taken pretreatment (A) and posttreatment (B) after one dose of nivolumab plus ipilimumab, followed by one dose of single-agent nivolumab. The tumors initially showed arterial enhancement consistent with HCC but lost this enhancement after treatment.